Andere Sprachen Neuronetics, Inc.

Aktien

A2JPMY

US64131A1051

STIM

Medizinische Ausrüstung

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 13.06.2025			% 5 Tage	% 1. Jan.
3,790 ^USD	-0,52 %		+1,88 %	+135,40 %

10.06.	Neuronetics gibt klinische Präsenz auf der Jahrestagung 2025 der Clinical TMS Society und Fortschritte im personalisierten Behandlungsprogramm von Greenbrook bekannt	RE
02.06.	Neuronetics wird in die Indizes Russell 2000® und Russell 3000® aufgenommen	RE

Andere Sprachen

Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program	10.06.
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program	10.06.
Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes	02.06.
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes	02.06.
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month	14.05.
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month	14.05.
Neuronetics : STIM Corporate Presentation May 2025	06.05.
Neuronetics: Q1 Earnings Snapshot	06.05.
Neuronetics Reports First Quarter 2025 Financial and Operating Results	06.05.
Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	06.05.
Neuronetics, Inc Announces Retirement of Steve Furlong as Chief Financial Officer, Effective March 31, 2026	06.05.
Neuronetics, Inc. Revises Earnings Guidance for the Full Year 2025	06.05.
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025	06.05.
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	05.05.
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call	22.04.
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression	31.03.
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression	31.03.
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4	27.03.
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results	27.03.
Neuronetics : Supplemental Financial and Operating Information	04.03.
Neuronetics: Q4 Earnings Snapshot	04.03.
Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results	04.03.
Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025	04.03.
Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	04.03.
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	03.03.

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Neuronetics, Inc.

Aktien

A2JPMY

US64131A1051

STIM

Medizinische Ausrüstung

Andere Sprachen

Filter